Irbaz Bin Riaz1,2, Rabbia Siddiqi3, Umar Zahid4, Urshila Durani1,2, Kaneez Fatima3, Qurat-Ul-Ain Riaz Sipra5, Ammad I Raina6, Muhammad Zain Farooq7, Alanna M Chamberlain8, Zhen Wang9, Ronald S Go2, Ariela L Marshall2, Faisal Khosa10. 1. Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, MN. 2. Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN. 3. Dow University of Health Sciences, Karachi, Pakistan. 4. Department of Medicine, John Hopkins, Baltimore, MD. 5. Department of Internal Medicine, University of Arizona, Tucson, AZ. 6. Department of Internal Medicine, Midwestern University, Glendale, AZ. 7. Department of Internal Medicine, Cook County Hospital, Chicago, IL. 8. Division of Epidemiology, Department of Health Sciences Research, Mayo Clinic, Rochester, MN. 9. Division of Health Care Policy and Research, Department of Health Sciences Research, Mayo Clinic, Rochester, MN. 10. Vancouver General Hospital, Vancouver, British Columbia, Canada.
Abstract
PURPOSE: Gender disparity persists in academic medicine. Female faculty are underrepresented in leadership positions and have lower research output. We studied gender differences in faculty rank and departmental leadership and contributing factors among academic hematologists and oncologists in the United States. METHODS: For clinical faculty at 146 hematology or oncology fellowship programs listed in the Fellowship and Residency Electronic Interactive Database, we collected data on demographics, academic rank, and research output using the Doximity and Scopus databases. We compared unadjusted characteristics of men and women by using 2-sided t tests and χ2 tests where appropriate. To predict probability of full professorship or leadership position among men versus women, we performed multivariable logistic regression analysis adjusted for clinical experience in years, number of publications, h-index, clinical trial investigator status, National Institutes of Health funding, and workplace ranking (top 20 v not). RESULTS: Two thousand one hundred sixty academic hematologists and oncologists were included. Women composed 21.9% (n = 142) of full professors, 35.7% (n = 169) of associate professors, and 45.4% (n = 415) of assistant professors. Thirty percent (n = 70) of departmental leaders were women. Female faculty, compared with male faculty, had a lower mean h-index (12.1 v 20.9, respectively; P < .001) and fewer years of professional experience since fellowship (10 v 16 years, respectively; P < .001). After adjusting for duration of clinical experience, academic productivity, and workplace ranking, the odds of obtaining professorship (odds ratio [OR], 1.05; 95% CI, 0.71 to 1.57; P = .85) or divisional leadership (OR, 0.57; 95% CI, 0.20 to 1.58; P = .28) for female physicians were not different compared with male physicians. CONCLUSION: Gender disparity exists in senior ranks of academic hematology and oncology; however, gender is not a significant predictor in achieving professorship or department leadership position.
PURPOSE: Gender disparity persists in academic medicine. Female faculty are underrepresented in leadership positions and have lower research output. We studied gender differences in faculty rank and departmental leadership and contributing factors among academic hematologists and oncologists in the United States. METHODS: For clinical faculty at 146 hematology or oncology fellowship programs listed in the Fellowship and Residency Electronic Interactive Database, we collected data on demographics, academic rank, and research output using the Doximity and Scopus databases. We compared unadjusted characteristics of men and women by using 2-sided t tests and χ2 tests where appropriate. To predict probability of full professorship or leadership position among men versus women, we performed multivariable logistic regression analysis adjusted for clinical experience in years, number of publications, h-index, clinical trial investigator status, National Institutes of Health funding, and workplace ranking (top 20 v not). RESULTS: Two thousand one hundred sixty academic hematologists and oncologists were included. Women composed 21.9% (n = 142) of full professors, 35.7% (n = 169) of associate professors, and 45.4% (n = 415) of assistant professors. Thirty percent (n = 70) of departmental leaders were women. Female faculty, compared with male faculty, had a lower mean h-index (12.1 v 20.9, respectively; P < .001) and fewer years of professional experience since fellowship (10 v 16 years, respectively; P < .001). After adjusting for duration of clinical experience, academic productivity, and workplace ranking, the odds of obtaining professorship (odds ratio [OR], 1.05; 95% CI, 0.71 to 1.57; P = .85) or divisional leadership (OR, 0.57; 95% CI, 0.20 to 1.58; P = .28) for female physicians were not different compared with male physicians. CONCLUSION: Gender disparity exists in senior ranks of academic hematology and oncology; however, gender is not a significant predictor in achieving professorship or department leadership position.
Authors: Laura S Graham; Alexandra O Sokolova; Ali Raza Khaki; Qian Vicky Wu; Nancy E Davidson Journal: Cancer Invest Date: 2020-11-11 Impact factor: 2.176
Authors: Ben Li; Jean Jacob-Brassard; Fahima Dossa; Konrad Salata; Teruko Kishibe; Elisa Greco; Nancy N Baxter; Mohammed Al-Omran Journal: BMJ Open Date: 2021-11-02 Impact factor: 2.692
Authors: Ruchika Talwar; Adrien Bernstein; Amanda Jones; Juanita Crook; Andrea B Apolo; Jennifer M Taylor; Lauren M Burke; Elizabeth R Plimack; Sima P Porten; Kirsten L Greene; Sarah P Psutka; Angela B Smith Journal: Urology Date: 2020-08-13 Impact factor: 2.633